vs

Side-by-side financial comparison of Cooper-Standard Holdings Inc. (CPS) and DENTSPLY SIRONA Inc. (XRAY). Click either name above to swap in a different company.

DENTSPLY SIRONA Inc. is the larger business by last-quarter revenue ($961.0M vs $672.4M, roughly 1.4× Cooper-Standard Holdings Inc.). Cooper-Standard Holdings Inc. runs the higher net margin — 0.5% vs -15.2%, a 15.7% gap on every dollar of revenue. On growth, DENTSPLY SIRONA Inc. posted the faster year-over-year revenue change (6.2% vs 1.8%). DENTSPLY SIRONA Inc. produced more free cash flow last quarter ($60.0M vs $44.6M).

Cooper Standard Automotive Inc., headquartered in Novi, Michigan, is a leading global supplier of systems and components for the automotive industry. Products include rubber and plastic sealing, fuel and brake lines, fluid transfer hoses and anti-vibration systems. Cooper Standard employs approximately 32,000 people globally and operates in 20 countries around the world. During World War II Standard Products produced 247,100 M1 Carbines, with the receiver of the carbines marked: "STD. PRO". T...

Dentsply Sirona Inc. is an American dental equipment manufacturer and dental consumables producer that markets its products in over 120 countries. It has factories in 21 countries. The present company is largely the result of a merger in 1993 in which Gendex Corporation acquired Dentsply International Inc. for $590 million.

CPS vs XRAY — Head-to-Head

Bigger by revenue
XRAY
XRAY
1.4× larger
XRAY
$961.0M
$672.4M
CPS
Growing faster (revenue YoY)
XRAY
XRAY
+4.4% gap
XRAY
6.2%
1.8%
CPS
Higher net margin
CPS
CPS
15.7% more per $
CPS
0.5%
-15.2%
XRAY
More free cash flow
XRAY
XRAY
$15.4M more FCF
XRAY
$60.0M
$44.6M
CPS

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CPS
CPS
XRAY
XRAY
Revenue
$672.4M
$961.0M
Net Profit
$3.3M
$-146.0M
Gross Margin
10.4%
46.1%
Operating Margin
0.1%
-14.5%
Net Margin
0.5%
-15.2%
Revenue YoY
1.8%
6.2%
Net Profit YoY
-91.7%
66.0%
EPS (diluted)
$0.19
$-0.74

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CPS
CPS
XRAY
XRAY
Q4 25
$672.4M
$961.0M
Q3 25
$695.5M
$904.0M
Q2 25
$706.0M
$936.0M
Q1 25
$667.1M
$879.0M
Q4 24
$660.8M
$905.0M
Q3 24
$951.0M
Q2 24
$984.0M
Q1 24
$0
$953.0M
Net Profit
CPS
CPS
XRAY
XRAY
Q4 25
$3.3M
$-146.0M
Q3 25
$-7.6M
$-427.0M
Q2 25
$-1.4M
$-45.0M
Q1 25
$1.6M
$20.0M
Q4 24
$40.2M
$-430.0M
Q3 24
$-494.0M
Q2 24
$-4.0M
Q1 24
$-31.7M
$18.0M
Gross Margin
CPS
CPS
XRAY
XRAY
Q4 25
10.4%
46.1%
Q3 25
12.5%
48.8%
Q2 25
13.2%
52.4%
Q1 25
11.6%
53.0%
Q4 24
12.4%
49.3%
Q3 24
52.1%
Q2 24
51.9%
Q1 24
53.1%
Operating Margin
CPS
CPS
XRAY
XRAY
Q4 25
0.1%
-14.5%
Q3 25
3.8%
-24.1%
Q2 25
5.3%
-13.7%
Q1 25
3.3%
7.2%
Q4 24
4.8%
-56.2%
Q3 24
-48.6%
Q2 24
5.1%
Q1 24
4.4%
Net Margin
CPS
CPS
XRAY
XRAY
Q4 25
0.5%
-15.2%
Q3 25
-1.1%
-47.2%
Q2 25
-0.2%
-4.8%
Q1 25
0.2%
2.3%
Q4 24
6.1%
-47.5%
Q3 24
-51.9%
Q2 24
-0.4%
Q1 24
1.9%
EPS (diluted)
CPS
CPS
XRAY
XRAY
Q4 25
$0.19
$-0.74
Q3 25
$-0.43
$-2.14
Q2 25
$-0.08
$-0.22
Q1 25
$0.09
$0.10
Q4 24
$2.30
$-2.09
Q3 24
$-2.46
Q2 24
$-0.02
Q1 24
$-1.81
$0.09

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CPS
CPS
XRAY
XRAY
Cash + ST InvestmentsLiquidity on hand
$191.7M
$326.0M
Total DebtLower is stronger
$1.0B
$2.3B
Stockholders' EquityBook value
$-83.5M
$1.3B
Total Assets
$1.8B
$5.4B
Debt / EquityLower = less leverage
1.70×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CPS
CPS
XRAY
XRAY
Q4 25
$191.7M
$326.0M
Q3 25
$147.6M
$363.0M
Q2 25
$121.6M
$359.0M
Q1 25
$140.4M
$398.0M
Q4 24
$170.0M
$272.0M
Q3 24
$296.0M
Q2 24
$279.0M
Q1 24
$114.2M
$291.0M
Total Debt
CPS
CPS
XRAY
XRAY
Q4 25
$1.0B
$2.3B
Q3 25
$1.1B
Q2 25
$1.1B
Q1 25
$1.1B
Q4 24
$1.1B
$1.7B
Q3 24
Q2 24
Q1 24
$1.1B
Stockholders' Equity
CPS
CPS
XRAY
XRAY
Q4 25
$-83.5M
$1.3B
Q3 25
$-102.3M
$1.5B
Q2 25
$-97.6M
$2.0B
Q1 25
$-114.7M
$2.0B
Q4 24
$-125.8M
$1.9B
Q3 24
$2.5B
Q2 24
$3.1B
Q1 24
$-115.8M
$3.3B
Total Assets
CPS
CPS
XRAY
XRAY
Q4 25
$1.8B
$5.4B
Q3 25
$1.9B
$5.7B
Q2 25
$1.8B
$6.1B
Q1 25
$1.8B
$6.0B
Q4 24
$1.7B
$5.8B
Q3 24
$6.6B
Q2 24
$6.9B
Q1 24
$1.8B
$7.1B
Debt / Equity
CPS
CPS
XRAY
XRAY
Q4 25
1.70×
Q3 25
Q2 25
Q1 25
Q4 24
0.90×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CPS
CPS
XRAY
XRAY
Operating Cash FlowLast quarter
$56.2M
$101.0M
Free Cash FlowOCF − Capex
$44.6M
$60.0M
FCF MarginFCF / Revenue
6.6%
6.2%
Capex IntensityCapex / Revenue
1.7%
4.3%
Cash ConversionOCF / Net Profit
16.90×
TTM Free Cash FlowTrailing 4 quarters
$16.3M
$104.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CPS
CPS
XRAY
XRAY
Q4 25
$56.2M
$101.0M
Q3 25
$38.6M
$79.0M
Q2 25
$-15.6M
$48.0M
Q1 25
$-14.9M
$7.0M
Q4 24
$74.7M
$87.0M
Q3 24
$141.0M
Q2 24
$208.0M
Q1 24
$-14.2M
$25.0M
Free Cash Flow
CPS
CPS
XRAY
XRAY
Q4 25
$44.6M
$60.0M
Q3 25
$27.4M
$40.0M
Q2 25
$-23.4M
$16.0M
Q1 25
$-32.4M
$-12.0M
Q4 24
$63.2M
$36.0M
Q3 24
$98.0M
Q2 24
$156.0M
Q1 24
$-31.0M
$-9.0M
FCF Margin
CPS
CPS
XRAY
XRAY
Q4 25
6.6%
6.2%
Q3 25
3.9%
4.4%
Q2 25
-3.3%
1.7%
Q1 25
-4.9%
-1.4%
Q4 24
9.6%
4.0%
Q3 24
10.3%
Q2 24
15.9%
Q1 24
-0.9%
Capex Intensity
CPS
CPS
XRAY
XRAY
Q4 25
1.7%
4.3%
Q3 25
1.6%
4.3%
Q2 25
1.1%
3.4%
Q1 25
2.6%
2.2%
Q4 24
1.7%
5.6%
Q3 24
4.5%
Q2 24
5.3%
Q1 24
3.6%
Cash Conversion
CPS
CPS
XRAY
XRAY
Q4 25
16.90×
Q3 25
Q2 25
Q1 25
-9.57×
0.35×
Q4 24
1.86×
Q3 24
Q2 24
Q1 24
1.39×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CPS
CPS

Sealing Systems$357.8M53%
Fluid Handling Systems$297.1M44%
Corporate And Other Segment$17.4M3%
Commercial$6.6M1%

XRAY
XRAY

Essential Dental Solutions$372.0M39%
Equipment And Instruments$160.0M17%
Implants And Prosthetics$150.0M16%
CADCAM$139.0M14%
Wellspect Healthcare$88.0M9%
Orthodontics$52.0M5%

Related Comparisons